Somewhere in your body right now, the largest blood vessel you own—the aorta—is carrying every drop of blood your heart pumps out to the rest of your body. This remarkable vessel stretches from the top of your heart, arches over like a walking cane, descends through your chest, passes through your diaphragm, and continues through your abdomen before splitting into the two iliac arteries that supply your legs. It is roughly the diameter of a garden hose, and it handles immense pressure with every heartbeat—approximately 100,000 times per day, every day of your life.
An aortic aneurysm occurs when a section of this vital vessel weakens and begins to balloon outward, like a weak spot in an old tire. The aneurysm grows slowly, silently, producing no symptoms whatsoever in most cases. And then, without warning, it can rupture—tearing open with catastrophic internal bleeding that kills 80 to 90 percent of victims, many before they reach a hospital.
Aortic aneurysms cause approximately 10,000 deaths annually in the United States, making them a significant cause of preventable mortality. The word "preventable" is key, because aortic aneurysms are detectable with simple, painless screening, and when detected before rupture, they can be monitored and treated with survival rates exceeding 95 percent. The challenge is finding them before they find you.
What an Aortic Aneurysm Is
An aneurysm is a localized dilation of a blood vessel—a section where the vessel wall has weakened and stretched outward beyond its normal diameter. The aorta's normal diameter is approximately 2 to 2.5 centimeters in the abdomen. An abdominal aortic aneurysm (AAA) is typically defined as a dilation exceeding 3 centimeters, though the clinical significance depends on both absolute size and rate of growth.
Aortic aneurysms are classified by location. Abdominal aortic aneurysms, occurring below the diaphragm, account for approximately 75 percent of aortic aneurysms and are the type most amenable to screening. Thoracic aortic aneurysms occur in the chest portion of the aorta. Thoracoabdominal aneurysms span both regions and are the most complex to treat.
The danger of an aneurysm is directly related to its size. As the aorta dilates, the wall becomes progressively thinner (like a balloon being inflated) while simultaneously experiencing greater wall stress (Laplace's law dictates that wall tension increases with vessel diameter). This creates a self-accelerating process: as the aneurysm grows, the conditions that promote further growth and eventual rupture intensify.
Small aneurysms (3 to 4 centimeters) have an annual rupture risk of less than 1 percent. Medium aneurysms (4 to 5 centimeters) have an annual rupture risk of 1 to 3 percent. Large aneurysms (5 to 5.5 centimeters) have an annual rupture risk of 3 to 15 percent. Very large aneurysms (above 6 centimeters) have an annual rupture risk of 20 to 40 percent or higher. These risk estimates inform the surveillance schedules and treatment thresholds used in clinical practice.
Why They Develop
Aortic aneurysms result from the degradation of the structural proteins—elastin and collagen—that give the aortic wall its strength and elasticity. Multiple factors contribute to this degradation.
Atherosclerosis
Atherosclerotic plaque development in the aortic wall triggers chronic inflammation that damages the structural integrity of the vessel. The inflammatory cells recruited to atherosclerotic plaques release enzymes called matrix metalloproteinases (MMPs) that break down elastin and collagen in the aortic wall, weakening it and promoting dilation. This is why aortic aneurysms share many of the same risk factors as coronary artery disease and peripheral artery disease.
Genetic and Connective Tissue Factors
Some people are genetically predisposed to aortic aneurysm development due to inherited variations in the genes controlling connective tissue proteins. Marfan syndrome, Ehlers-Danlos syndrome (type IV), Loeys-Dietz syndrome, and familial thoracic aortic aneurysm syndromes all involve genetic mutations that weaken the aortic wall.
Even without a recognized connective tissue syndrome, family history is a strong risk factor. Having a first-degree relative with an aortic aneurysm increases your risk by approximately four to ten times. This familial clustering suggests that multiple genetic variants, each conferring modest risk, can collectively create significant vulnerability.
Smoking: The Dominant Modifiable Risk Factor
Smoking is the single most important modifiable risk factor for abdominal aortic aneurysm. Current smokers have a three to six times higher risk of developing AAA compared to never-smokers, and the risk remains elevated for years after quitting, though it does gradually decline. Smoking promotes aneurysm development through direct toxic effects on elastin, increased MMP activity, chronic inflammation of the vascular wall, and accelerated atherosclerosis.
The association between smoking and AAA is so strong that smoking history is the primary factor driving screening recommendations. The United States Preventive Services Task Force recommends one-time screening ultrasound for AAA in men aged 65 to 75 who have ever smoked.
Other Risk Factors
Additional risk factors include male sex (men are four to six times more likely than women to develop AAA), age over 65, hypertension, hyperlipidemia, chronic obstructive pulmonary disease, and peripheral artery disease. Each of these factors reflects either direct vascular wall stress or the systemic vascular disease that promotes aneurysm development.
The Silent Nature of Aneurysms
The most dangerous aspect of aortic aneurysms is their silence. The vast majority of aneurysms produce absolutely no symptoms as they grow. There is no pain, no discomfort, no shortness of breath, no visible sign. The aorta sits deep within the abdomen or chest, surrounded by other organs, and its gradual dilation occurs without disturbing any pain-sensitive structures until it either reaches a very large size or ruptures.
Occasionally, a large abdominal aneurysm may produce a pulsating sensation in the abdomen, back pain, or a feeling of fullness, but these symptoms are nonspecific and easily attributed to other causes. Many aortic aneurysms are discovered incidentally during imaging studies performed for other reasons—a CT scan for kidney stones, an ultrasound for gallbladder symptoms, or a physical exam where an astute physician feels a pulsatile abdominal mass.
This silent growth makes screening the only reliable detection method. Waiting for symptoms is waiting for a catastrophe.
When Rupture Occurs
Aortic aneurysm rupture is a true medical emergency—one of the most time-critical emergencies in all of medicine. When the weakened aortic wall tears, blood under arterial pressure pours into the abdominal cavity (for AAA) or chest cavity (for thoracic aneurysms), causing hemorrhagic shock.
Symptoms of rupture include sudden, severe abdominal or back pain (often described as a "tearing" sensation), lightheadedness, rapid pulse, cold and clammy skin, and loss of consciousness. The mortality rate for ruptured AAA is approximately 80 to 90 percent overall, including those who die before reaching the hospital. Even among patients who reach the operating room alive, the surgical mortality rate is 40 to 50 percent.
These grim statistics underscore the entire rationale for screening: finding and treating aneurysms before rupture transforms a condition with 80 to 90 percent mortality into one with 1 to 5 percent mortality.
Screening: Simple, Painless, Lifesaving
Screening for abdominal aortic aneurysm is performed with a simple abdominal ultrasound—a painless, non-invasive test that takes approximately ten minutes, involves no radiation, and accurately measures the aortic diameter with high sensitivity and specificity.
Who Should Be Screened
Current guidelines from the USPSTF recommend one-time screening with abdominal ultrasound for men aged 65 to 75 who have ever smoked (including those who quit decades ago). This recommendation is based on strong evidence that screening in this population reduces AAA-related mortality by approximately 45 percent.
For men aged 65 to 75 who have never smoked, the USPSTF suggests selective screening based on individual risk factors—particularly family history and the presence of other vascular disease.
For women, the evidence for routine screening is less clear. While AAA is less common in women, it tends to be diagnosed later, ruptures at smaller diameters, and has worse surgical outcomes. Women with significant risk factors (smoking history, family history of AAA) should discuss screening with their healthcare provider.
If you have a first-degree relative with a known aortic aneurysm, screening should begin earlier—typically at age 55—and may need to be repeated if initial screening is normal.
What Happens After Screening
If screening ultrasound shows a normal aortic diameter (below 3 centimeters), no further surveillance is typically needed. The risk of developing a significant aneurysm after a normal screening result is very low.
If a small aneurysm is detected (3 to 4.4 centimeters), surveillance ultrasound is recommended every two to three years to monitor for growth. No treatment is needed at this stage, but awareness allows timely intervention if the aneurysm enlarges.
If a medium aneurysm is detected (4.5 to 5.4 centimeters), surveillance intervals shorten to every six to twelve months. The aneurysm is approaching the treatment threshold, and close monitoring ensures that intervention occurs before the rupture risk becomes unacceptable.
If a large aneurysm is detected (5.5 centimeters or above in men, 5.0 centimeters or above in women, or rapid growth exceeding 0.5 centimeters in six months), treatment is recommended regardless of symptoms.
Treatment Options
When an aneurysm reaches the treatment threshold, two primary approaches are available.
Open Surgical Repair
Traditional open repair involves a major abdominal operation in which the surgeon exposes the aorta, clamps it above and below the aneurysm, opens the aneurysm, and sews in a synthetic graft to replace the diseased segment. This operation has been performed since the 1950s and has excellent long-term durability—grafts typically last for the rest of the patient's life.
Open repair requires general anesthesia, a large abdominal incision, significant recovery time (typically one to two weeks in the hospital and two to three months for full recovery), and carries a perioperative mortality risk of approximately 3 to 5 percent in specialized centers.
Endovascular Aneurysm Repair (EVAR)
EVAR is a minimally invasive alternative in which a collapsed stent-graft is threaded through the femoral arteries in the groin and positioned within the aneurysm under X-ray guidance. Once in place, the graft expands, lining the inside of the aneurysm and diverting blood flow through the graft rather than against the weakened aneurysm wall.
EVAR requires only small incisions in the groin, can often be performed under regional or local anesthesia, involves shorter hospital stays (one to three days), faster recovery (two to six weeks), and carries a lower perioperative mortality risk of approximately 1 to 2 percent.
The tradeoff is that EVAR requires lifetime imaging surveillance to monitor for graft complications (endoleaks, migration, component separation), and a small percentage of patients require secondary procedures over time. Not all aneurysm anatomies are suitable for EVAR—the shape, size, and location of the aneurysm must be compatible with available graft devices.
The choice between open repair and EVAR depends on the patient's anatomy, age, overall health, surgical risk, and the specific characteristics of the aneurysm. Both approaches are performed routinely at vascular surgery centers with excellent outcomes.
Reducing Your Risk
While some risk factors for aortic aneurysm (age, sex, genetics) cannot be modified, several interventions can reduce your risk or slow the progression of existing aneurysms.
Quitting smoking is the single most impactful action. Smoking cessation slows aneurysm growth, reduces rupture risk, and improves surgical outcomes if treatment becomes necessary.
Blood pressure control reduces the mechanical stress on the aortic wall with every heartbeat. Beta-blockers and ACE inhibitors are commonly used in patients with known aneurysms, though evidence for specific medication classes in slowing aneurysm growth is still evolving.
Cholesterol management with statins reduces the atherosclerotic inflammation that drives aortic wall degradation. Observational studies suggest that statin therapy may slow aneurysm growth, though definitive trial evidence is pending.
Regular cardiovascular risk factor management—exercise, healthy diet, weight management—supports overall vascular health and may indirectly reduce aneurysm risk by reducing the inflammatory and metabolic stressors that contribute to vascular disease.
The Power of Knowing
An aortic aneurysm detected by screening is a manageable condition. An aortic aneurysm that ruptures without warning is a catastrophe. The difference between these two outcomes is a ten-minute ultrasound that costs very little, hurts not at all, and can save your life.
If you are a man aged 65 to 75 who has ever smoked, get screened. If you have a family history of aortic aneurysm, discuss screening with your doctor regardless of your age or smoking history. If your doctor discovers an aneurysm incidentally on imaging performed for another reason, take it seriously and follow up with the recommended surveillance schedule.
The silent killer earns its name by operating in darkness. Screening turns on the light.
Sources and Further Reading
Health and Beyond uses reputable medical and scientific sources where possible. These links support or expand on the topics discussed above.
- United States Preventive Services Task Forceuspreventiveservicestaskforce.org
- USPSTF recommend one-time screeninguspreventiveservicestaskforce.org
